Achieving uniformity in the care rendered to patients with wounds has been a major desire of clinicians, government regulators, and third-party payers. 1 One of the goals of the founders of the Wound Healing Society (WHS) in 1991 was to establish guidelines for wound treatment. One of the first tasks of the WHS Board of Directors following the first annual meeting in Galveston, TX, was to appoint a committee to develop treatment guidelines. 1 This committee, under the direction of Gerald S. Lazarus, MD, realized that uniform care guidelines could not be developed because there was no uniformity in the definitions of wounds, wound healing, or wound attributes. The committee developed the necessary definitions and after several public hearings, the article ''Definitions and guidelines for assessment of wounds and evaluation of healing'' was published in 1994. 2 That publication defined an acute wound as one that proceeds through an orderly and timely reparative process to establish sustained anatomic and functional integrity, and defined a chronic wound as one that has failed to proceed through an orderly and timely reparative process to produce anatomic and functional integrity or has proceeded through the repair process without establishing a sustained anatomic and functional result. 2 Simply stated, wounds may be classified as those that can repair themselves or can be repaired in an orderly and timely process (acute wounds) and those that cannot (chronic wounds).
In 2006, the WHS published ''Guidelines for the best care of chronic wounds.'' 1 The chronic wounds chosen for treatment guideline development were venous, diabetic, arterial, and pressure ulcers. Because chronic wounds have impaired healing, evidence-based guidelines were developed to maximize healing trajectories and accelerate healing where possible. However, acute wounds are much more numerous than chronic wounds. There are 50,000,000 elective surgical incisions made each year in the United States, and another 50,000,000 traumatic wounds. 3 Add to this 1 million burn injuries and the scope of the problem becomes clear. As opposed to the chronic wound, healing in the acute wound is taken for granted. 4 It is assumed that if one debrides a wound of nonviable tissue and repairs it in a physiologic manner, the normal phases of wound healing-reaction, regeneration, remodelingshould proceed without difficulty. 3, 4, 5 Acute wounds are expected to heal with a ''normal'' wound healing trajectory 3 ; hence, accelerating healing has not been the goal in their treatment. Rather, the goal has been to remove detriments or deterrents to normal healing and eliminate the complications that may prevent an orderly and timely reparative process that could convert the acute wound into a chronic wound.
A panel was appointed to develop guidelines to ''aid healing of acute wounds by decreasing impediments to healing.'' The panel consisted of general, vascular, plastic, trauma, burn, and cancer surgeons, nurse clinicians, and researchers drawn from academic, governmental, private practice, and industrial settings. These panel members represented most scientific, medical, and nursing societies/associations that have wound care as a major scope of interest. The panel limited the scope of acute wound healing to integument and soft tissue, and did not address bone, cartilage, neural tissue, or internal organs.
The approach used for evidence citations was the same as for the chronic wound guidelines. Major differences exist between this approach to evidence citations compared with past approaches to evidence-based guidelines. Most past approaches relied only on publications regarding clinical human studies. Laboratory or animal studies were not cited. The approach used here and in the previously published guidelines for treatment of chronic wounds used well-controlled animal studies that present proof of principle, especially when a clinical series corroborated the laboratory results. Because of these variations, a different system was used to grade the evidence weight supporting a given guideline. The level strength of evidence supporting a guideline is listed as Level I, Level II, or Level III. The guideline criteria for the levels are:
Level I: Meta-analysis of multiple RCTs or at least two RCTs support the intervention of the guideline. Another route would be multiple laboratory or animal experiments with at least two clinical series supporting the laboratory results. Level II: Less than Level I, but at least one RCT and at least two significant clinical series or expert opinion papers with literature analysis, RCT, or multiple clinical series. Level III: Suggestive data of proof of principle, but lacking sufficient data such as meta-analysis, RCT, or multiple clinical series. NB: The suggestion in the guideline can be positive or negative at the proposed level (e.g., meta-analysis and two RCTs stating intervention is not an aid for decreasing impediments to healing).
RESULTS
Guidelines have been formulated in 11 categories of impediments to acute wound healing reported to lead to significant complications to normal tissue repair. The categories have been separated into five impediments that are local to the wound environment and six that are systemic conditions affecting the healing of acute wounds. These categories are:
Local:
Wound perfusion Tissue viability Hematoma and/or seroma Infection Mechanical factors
Systemic:
Immunology Oncology Miscellaneous systemic conditions Thermal injuries External agents Excessive scarring Each of the guidelines underwent a DELPHI consensus among the panel members. Each set was critically evaluated by all panel members. There was a consensus of at least 10 of 11 panel members on each individual guideline. The majority of the guidelines had unanimous concurrence. The resultant draft, ''Guidelines to aid healing of acute wounds by decreasing impediments to healing,'' was then reviewed by the WHS Board of Directors and posted on its website for public review and comment. All comments received by these two review processes were evaluated and modifications were made in the final document. The final document is presented as follows:
#1: Guidelines to decrease the impediment to acute wound healing caused by inadequate wound perfusion #2: Guidelines to decrease the impediment to acute wound healing caused by nonviable tissue #3: Guidelines to decrease the impediment to acute wound healing caused by wound hematoma or seroma #4: Guidelines to decrease the impediment to acute wound healing caused by infection or an increased tissue bioburden #5: Guidelines to decrease the impediment to acute wound healing caused by mechanical factors during wound repair #6: Guidelines to decrease the impediment to acute wound healing caused by systemic immune deficiencies #7: Guidelines to decrease the impediment to acute wound healing caused by cancer and its treatment #8: Guidelines to decrease the impediment to acute wound healing caused by systemic conditions such as diabetes mellitus, obesity, malnutrition, etc #9: Guidelines to decrease the impediment to acute wound healing caused by burn injuries #10: Guidelines to decrease the impediment to acute wound healing caused by external agents such as tobacco, drugs, etc. Guideline #3.1: Coagulation should preferentially be normalized preoperatively; correction should continue intraoperatively and for 24 hours following a surgical procedure. Primary coagulopathies such as vitamin K deficiency or hemophilia should be diagnosed and treated before elective operations. Therapeutic anticoagulation, as with warfarin, can be temporarily discontinued and ''bridged'' with shorter-acting anticoagulants. Prophylactic heparins to prevent venous thromboembolism (VTE) are indicated, but will increase the risk of hematomas and other bleeding complications. Antiplatelet agents may be continued during general surgical procedures.
Level of evidence: I Principle: Bleeding complications, including hematoma formation, are significantly increased when a primary or pharmacological coagulopathy exists. The most common mechanism for coagulopathy is impaired or reduced protein-clotting factors and impaired or reduced platelets. Patients at high risk for a hypercoagulable complication such as stroke, myocardial ischemia, or VTE may be ''bridged'' with a heparin formulation that can be held during the 24-hour period surrounding an operation. Heparin prophylaxis against VTE is indicated in general surgery, but will increase the incidence of hematoma and bleeding complications. There is no evidence that prophylactic or therapeutic antiplatelet therapy increases the risk of acute wound hematomas. Guideline #3.2: Meticulous surgical hemostasis by ligature or electrocautery reduces the incidence of wound hematoma formation and improves wound healing.
Level of evidence: I Principle: Surgical hemostasis prevents hematoma formation. Larger bleeding vessels in a wound should be clamped and tied with an absorbable suture. Electrocautery is an option for wound hemostasis, as are topical chemical hemostatic agents. Primary layered anatomic closure of an incision results in most efficient hemostasis, wound healing, and an optimized anatomic result. By achieving complete hemostasis, hematoma formation is minimized and ''dead space'' is eliminated, reducing the added risk of localized bacteria utilizing the hematoma as a nutrient media.
Evidence: Guideline #3.4: Large postoperative hematomas or seromas with evidence of wound ischemia or infection should be therapeutically drained or evacuated.
Level of evidence: I Principle: Wound hematomas or seromas may reach a pressure at which capillary perfusion pressure to the surrounding wound tissue is exceeded. The resulting wound ischemia may lead to acute wound failure or wound infection. Chronically, a wound hematoma may act as a nidus for a wound infection and abscess. Opening a surgical wound and evacuating the fluid or hematoma should correct both of these complications. In the patient who receives a minimally invasive surgical procedure where there are minimal skin incisions, such as following laparoscopic hernia repair, percutaneous aspiration may be attempted.
Evidence: Guideline #4.2: When wounds are considered at risk for having a significant bacterial bioburden (clean-contaminated or contaminated cases), prophylactic antibiotics are indicated. Clean cases with negligible bacterial bioburden do not benefit from prophylactic antibiotics except when implanted prosthetic materials are used.
Level of evidence: I Principle: Clean-contaminated and contaminated wounds result in higher rates of postoperative infection. Clean-refined and clean cases have infection rates that are low enough to make it difficult to demonstrate statistical improvement with prophylactic antibiotic usage. Guideline #4.3: When prophylactic antibiotics are to be used, they must be started preoperatively so as to obtain an adequate serum and, preferably, a tissue antimicrobial level before incision or wounding.
Level of evidence: I Principle: Antibiotics begun after bacterial tissue lodgment has occurred cannot favorably affect the bacterialhost defense balance.
Evidence: Guideline #4.4: When prophylactic antibiotics are indicated, a single dose is often sufficient. If multiple doses are used, they should be confined to a 24-hour period and not of prolonged duration.
Level of evidence: I
Principle: A single dose of the proper antibiotic, delivered at the proper time, will usually be effective at maintaining or reestablishing the bacteria-host defense equilibrium.
Evidence: 
#5: GUIDELINES TO DECREASE IMPEDIMENTS TO ACUTE WOUND HEALING CAUSED BY MECHANICAL FACTORS DURING WOUND REPAIR
Preamble: Mechanical factors play an important and often underappreciated role in acute wound healing. Primary closure of an incision stabilizes distractive forces to allow wound healing and an optimized anatomic result. Cellular studies confirm that mechanical load forces are an important signal for acute wound repair. When anatomic stability of a wound is achieved, a particular suture material or suturing technique is of secondary importance. The increased use of foreign material implants, such as meshes for hernia repair, are suggested to manipulate the mechanical environment of the acute wound, even to the point of promoting ''tension-free'' wound healing. Negative pressure wound therapy is increasingly applied to stabilize acute wounds and to support acute wound healing. Mechanical micro-deformation of repair cells in the wound bed is thought to stimulate acute wound healing. Guideline #5.2: Laparotomy fascial incisions heal best when repaired as a mass closure using a continuous suture placed at a suture-length-to-wound-length ratio of 4 : 1.
Level of evidence: I Principle: All incisions are placed under a strain following repair. An abdominal wall laparotomy incision extends 10% in length following repair. A continuous suture line placed at a suture-length-to-wound-length ratio of 4 : 1 allows the suture line to physiologically extend with the incision. This prevents suture ''pull through,'' which is the most common mechanism of suture failure. A 4 : 1 ratio also minimizes the amount of suture material required, reducing the foreign material inflammatory response in the healing wound. The appropriate suture-length-to-woundlength ratio also optimizes tension on the suture line, minimizing wound ischemia. Level of evidence: I Principle: The recurrence rate following inguinal hernia repairs using autologous tissues ranges from 5 to 25% in most series. The recurrence rate following primary incisional hernia repair using autologous tissues is even worse, ranging from 20 to 60%. The introduction of synthetic soft tissue prostheses to inguinal and incisional hernia repair has significantly reduced recurrence rates across general surgery. The prevailing view is that the mechanism for the reduced hernia recurrence rates is the reduction of tension along suture lines when using a soft-tissue prosthesis (mesh). Guideline #5.6: External or internal retention sutures do not prevent dehiscence or incisional hernia formation. Retention sutures do not improve laparotomy wound outcomes.
Level of evidence: I Principle: The incidence of clinically recognized acute laparotomy wound failure and dehiscence is at least 1%, with a mortality of > 50%. The incidence of unrecognized acute laparotomy wound failure and primary incisional hernia formation is at least 11%. Comorbidities such as multiple trauma and wound contamination increase the risk of acute laparotomy wound failure. Purely mechanical efforts to stabilize abdominal wall repairs during primary closure are generally unsuccessful.
Evidence: Guideline #5.7: Transverse laparotomy incisions do not form fewer incisional hernias than midline laparotomy incisions.
Level of evidence: I Principle: The predominant, load-bearing collagen fibers of the abdominal wall are transversely oriented. Incisions parallel to these fibers are least destructive in terms of loss of mechanical integrity. Transverse laparotomy closures encircle these same load-bearing fibers, maximizing mechanical integrity. Although theoretically the mechanical integrity is maximized in the transverse incision, laparotomy incisional herniation occurs at similar rates regardless of incisional orientation. Guideline #6.1: HIV seropositive patients, especially those with AIDS, should be maximally medically treated for that disease whenever possible before elective operations. Antiretroviral therapy should be initiated, viral load minimized, and absolute lymphocyte count maximized. Effective prophylaxis against wound infection should be used.
Level of evidence: I Principle: The effect of HIV infection on acute wound healing is multifactorial. Normal cellular immunity is required for normal acute wound healing. A complicating wound infection or associated systemic infection will impair acute wound healing. Finally, progressive malnutrition or hypoalbuminemia is an impediment to acute wound healing. Guideline #6.2: Immunosuppressant drug activity (level) should be minimized whenever possible during surgical procedures and until the acute wound is healed. In particular, steroid doses should be minimized before wounding and during wound healing. However, if an emergency procedure is necessary for a patient on steroids, the steroids must be supported throughout the procedure and weaned postoperatively.
Level of evidence: I Principle: The humoral and cellular inflammatory response is a fundamental part of the mechanism of acute wound healing. Defects in the early humoral and cellular immune response will increase the risk for both wound infection and acute, mechanical wound failure. Preamble: Malignant diseases will soon overtake cardiovascular disease as the leading cause of mortality in the United States. Malignant neoplasia is fundamentally dysregulated cellular proliferation, while wound healing represents regulated or controlled cellular proliferation. The mechanism of cancer therapy, therefore, usually involves the inhibition of cellular proliferation and function, which also will impair or prevent wound healing.
Guideline #7.1: Chemotherapeutic drugs impair wound healing. Attempts should be made to maximize the time between neo-adjuvant and adjuvant therapies and surgical wounding.
Level of evidence: I Principle: The most common chemotherapeutic agents are cytotoxic (nitrogen mustards and methylating agents), antiproliferative (microtubule stabilizers and DNA synthesis inhibitors), or antimetabolic (folic acid synthesis inhibitors). All of these pathways are normally activated during normal wound healing (benign neoplasia). Chemotherapeutic drugs therefore impair wound healing by the same mechanisms that they inhibit malignant cell growth. Level of evidence: I Principle: The healing of radiated tissue is impaired due mainly to fibrotic microangiopathy. The result is subthreshold tissue oxygen levels for normal acute wound healing. Technically, tissue planes are distorted due to fibrosis. Healing may be improved by increasing tissue oxygen levels, as with hyperbaric oxygen therapy.
Evidence: Guideline #7.3: Cancer patients may develop unique malnutrition syndromes (cancer cachexia). This is, in part, due to elevated tumor associated cytokine levels (tumor necrosis factor [TNF]). Enteral nutrient supplementation, but not parenteral nutrient supplementation, improves wound healing in cancer patients.
Level of evidence: I Principle: Hypoalbuminemia is a well-established marker for surgical complications, including impaired wound healing. Cancer patients often express protein malnutrition. In addition, cancer patients may express a unique malnutrition syndrome, cancer cachexia or cancer anorexia. It is believed that part of the mechanism for this paraneoplastic syndrome is elevated stress or inflammatory cytokines, especially TNF-a (cachexin). Cancer cachexia is also associated with surgical complications and poor wound healing.
Evidence: Guideline #8.2: Although older patients may have physiologic impairments in wound healing, the incidence of healing is similar to younger patients but at a slower rate.
Level of evidence: II Principle: In elderly patients without other significant medical conditions, the rate of wound healing is normal or mildly impaired. Systemic and regional medical conditions are more common in the aged and account for many of the delays in healing.
Evidence: Guideline #8.4: Nutrition must be adequate to provide metabolic support for healing. Weight and prealbumin and albumin levels are helpful in identifying patients who are malnourished and may need nutritional support.
Level of evidence: I Principle: The nutritional status of most people will allow normal healing to occur. Elderly patients, those with gastrointestinal problems or other debilitating illnesses, and patients institutionalized in long-term care facilities are at greater risk for malnutrition. Obesity, low albumin, and low protein levels are associated with an increased risk of wound dehiscence and infection. Nutritional supplements, including proteins, carbohydrates, fats, vitamins, minerals, and trace elements, improve healing and reduce the likelihood of surgical site infection, wound dehiscence, and hernia. Guideline #9.2: Scald burns in children, burns in the elderly, burns in patients with severe inhalation injury, and burns of special areas (hands and face) may be considered exceptions to early excision and grafting of deep burns.
Level of evidence: II Principle: Early excision and grafting can impose a significant insult to patients at the extremes of age or with significant comordid conditions such as smoke inhalation. It has been difficult to prove superior results for early excision and grafting of hand or facial burns.
Evidence:
(The effects of hyperbaric oxygen on acute wound healing are discussed in Guideline #1.3. The effects of anticoagulants on acute wound healing are discussed in Guideline #3.1. The effects of chemotherapeutic drugs on acute wound healing are discussed in Guideline #7.1.)
#11: GUIDELINES TO DECREASE THE IMPEDIMENT TO ACUTE WOUND HEALING CAUSED BY EXCESSIVE SCAR FORMATION
Preamble: In excessive healing or proliferative scarring, it is as if the equilibrium point between collagen deposition and collagen lysis is never reached. It is unclear why some wounds seem to continue in the repair processes without an apparent turnoff switch. Because of these unknowns, there is no universally accepted treatment regimen. In a recent metaanalysis of excessive scarring treatments, the mean amount of improvement to be expected was only 60%.
Guideline #11.1: Pressure garments or compression dressings are effective in decreasing scarring in burn injuries that require > 21 days to heal.
Level of evidence: I Principle: Excessive or hypertrophic scarring is rare in burn injuries that heal within 21 days. The exact mechanism by which pressure is effective is unknown.
